Discover 3,564 paid clinical trials in Long Beach, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,564
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
for
Chronic Spontaneous Urticaria
Location: Fountain Valley CA, Pasadena CA, Lancaster CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07219615
Phase2, Recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
for
Psoriatic Arthritis
Location: Fountain Valley CA, Tujunga CA, Thousand Oaks CA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06671483
Phase3, Recruiting
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Fountain Valley CA, Los Angeles CA, Fremont CA,
Sponsor: Oneness Biotech Co., Ltd.
Sex: All
Age: 18 - 65
Code: NCT06397911
Phase2, Recruiting
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
for
Chickenpox
Location: Huntington Park CA, Sherman Oaks CA, Tucson AZ,
Sponsor: GlaxoSmithKline
Sex: All
Age: 1
Code: NCT06855160
Phase3, Recruiting
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
for
Hypogammaglobulinemia, Bacterial Infections,
Location: Huntington Park CA, Bullhead City AZ, Canton OH,
Sponsor: Grifols Therapeutics LLC
Sex: All
Age: 18+
Code: NCT05645107
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
for
Prurigo Nodularis
Location: Fountain Valley CA, Santa Monica CA, Corona CA,
Sponsor: Galderma R&D
Sex: All
Age: 18+
Code: NCT06988618
Recruiting
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
for
Parkinson's Disease
Location: Fountain Valley CA, Los Angeles CA, Phoenix AZ,
Sponsor: Bayer
Sex: All
Age: 45 - 70+
Code: NCT07330258
Recruiting
A Study of Buntanetap in Participants With PD
for
Parkinson's Disease (PD), Deep Brain Stimulation
Location: Fountain Valley CA, Sun City AZ, Englewood CO,
Sponsor: Annovis Bio Inc.
Sex: All
Age: 40 - 70+
Code: NCT07284784
Phase2, Phase3, Recruiting
Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
for
Parkinson Disease
Location: Fountain Valley CA, Spokane WA, Farmington Hills MI,
Sponsor: Hillhurst Biopharmaceuticals, Inc.
Sex: All
Age: 40 - 70+
Code: NCT07005180
Phase2, Recruiting
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
for
Parkinson Disease
Location: Irvine CA, Aliso Viejo CA, Palo Alto CA, Boca Raton FL,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07219927
Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Fountain Valley CA, Los Angeles CA, Beverly Hills CA,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase2, Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for
Triple-Negative Breast Cancer
Location: Fountain Valley CA, Oceanside CA, La Jolla CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06393374
Phase3, Recruiting
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
for
Atrial Fibrillation
Location: Fountain Valley CA, Ventura CA, Murray UT, Austin TX,
Sponsor: Biosense Webster, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07523750
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
for
Non-Small Cell Lung Cancer (NSCLC)
Location: Fountain Valley CA, Beverly Hills CA, Bullhead City AZ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361510
Phase3, Recruiting
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
for
Atrial Fibrillation
Location: Fountain Valley CA, Ventura CA, Phoenix AZ, Tucson AZ,
Sponsor: Biosense Webster, Inc.
Sex: All
Age: 22+
Code: NCT07227532
Recruiting
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Fountain Valley CA, Los Angeles CA, Reno NV,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06899126
Phase3, Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Fountain Valley CA, Los Angeles CA, Santa Monica CA,
Location: Fountain Valley CA, Los Angeles CA, Pasadena CA,
Sponsor: Hamilton Health Sciences Corporation
Sex: All
Age: 18+
Code: NCT05963698
Recruiting
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
for
NSCLC Stage IV
Location: Fountain Valley CA, El Segundo CA, Spokane WA,
Sponsor: ImmunityBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06745908
Phase3, Recruiting
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients